Alerts will be sent to your verified email
Verify Email
WELCURE
|
Welcure Drugs&Pharma
|
Radford Global
|
Sinnar Bidi Udyog
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
43.2 % | 1.27 % | 0.84 % |
|
5yr average Equity Multiplier
|
-0.38 | 1.15 | 2.22 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 0.55 | 0.56 |
|
5yr Avg Net Profit Margin
|
-80.17 % | 1.92 % | 0.54 % |
|
Price to Book
|
0.3 | 2.07 | 8.3 |
|
P/E
|
1.14 | 321.43 | 113.1 |
|
5yr Avg Cash Conversion Cycle
|
2364.01 Days | 136.94 Days | 180.09 Days |
|
Inventory Days
|
20.66 Days | 328.67 Days | 362.18 Days |
|
Days Receivable
|
1232.42 Days | 55.38 Days | 12.32 Days |
|
Days Payable
|
0.0 | 84.73 Days | 210.66 Days |
|
5yr Average Interest Coverage Ratio
|
-2.67 | 1543.57 | 159.17 |
|
5yr Avg ROCE
|
-7.19 % | 1.85 % | 0.8 % |
|
5yr Avg Operating Profit Margin
|
-81.01 % | -1.23 % | -3.05 % |
|
5 yr average Debt to Equity
|
-0.35 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
-2.01 % | 31.95 % | -6.73 % |
|
5yr Average Return on Assets
|
-1.33 % | 1.07 % | 0.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 7.36 % | 73.4 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Welcure Drugs&Pharma
|
Radford Global
|
Sinnar Bidi Udyog
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|